Profitability
Weight: 25%
C
51
- 5yr Avg ROIC 4.2%
- Operating Margin Trend +1.89 pp/yr
JAZZ
Jazz Pharmaceuticals plc
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
21
- 5yr Avg ROE 0.2%
- 5yr Share-Count CAGR 1.5%
Growth Quality
Weight: 25%
A
90
- 5yr Revenue CAGR 12.5%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
A-
86
- 5yr FCF Margin 26.5%
- 5yr FCF/NI Conversion 2.49x
Balance Sheet
Weight: 10%
F
8
- Net Debt / EBITDA 11.35x
- Interest Coverage (EBIT/Int) -2.22x
- Altman Z-Score 1.66
Stability
Weight: 5%
B
70
- EPS Volatility (σ/μ) 0.25
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 2 added; 1 trimmed.
- Holders
- 3
- Avg Δ position
- +4.6%
- New buys
- 0
- Full exits
- 0
- Cooperman decreased -71%
- Wood increased +62%
- Greenblatt increased +22%